Davis CB - Search Results

1

Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LA, Davis CB. Zia-Amirhosseini P, et al. Among authors: davis cb. J Pharmacol Exp Ther. 1999 Dec;291(3):1060-7. J Pharmacol Exp Ther. 1999. PMID: 10565825

2

Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans.

Chow FS, Benincosa LJ, Sheth SB, Wilson D, Davis CB, Minthorn EA, Jusko WJ. Chow FS, et al. Among authors: davis cb. Clin Pharmacol Ther. 2002 Apr;71(4):235-45. doi: 10.1067/mcp.2002.122276. Clin Pharmacol Ther. 2002. PMID: 11956506 Clinical Trial.

3

A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis.

Mould DR, Davis CB, Minthorn EA, Kwok DC, Elliott MJ, Luggen ME, Totoritis MC. Mould DR, et al. Among authors: davis cb. Clin Pharmacol Ther. 1999 Sep;66(3):246-57. doi: 10.1016/S0009-9236(99)70032-9. Clin Pharmacol Ther. 1999. PMID: 10511060 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys.

Benincosa LJ, Chow FS, Tobia LP, Kwok DC, Davis CB, Jusko WJ. Benincosa LJ, et al. Among authors: davis cb. J Pharmacol Exp Ther. 2000 Feb;292(2):810-6. J Pharmacol Exp Ther. 2000. PMID: 10640322

5

Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4.

Sharma A, Davis CB, Tobia LA, Kwok DC, Tucci MG, Gore ER, Herzyk DJ, Hart TK. Sharma A, et al. Among authors: davis cb. J Pharmacol Exp Ther. 2000 Apr;293(1):33-41. J Pharmacol Exp Ther. 2000. PMID: 10734150

6

Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice.

Hepburn TW, Hart TK, Horton VL, Sellers TS, Tobia LP, Urbanski JJ, Shi W, Davis CB. Hepburn TW, et al. Among authors: davis cb. J Pharmacol Exp Ther. 2001 Sep;298(3):886-93. J Pharmacol Exp Ther. 2001. PMID: 11504781

7

Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.

Davis CB, Hepburn TW, Urbanski JJ, Kwok DC, Hart TK, Herzyk DJ, Demuth SG, Leland M, Rhodes GR. Davis CB, et al. Drug Metab Dispos. 1995 Oct;23(10):1028-36. Drug Metab Dispos. 1995. PMID: 8654189

8

Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Zia-Amirhosseini P, Harris RZ, Cowley HC, Valle JW, Citerone DR, Boppana VK, Scarffe H, Watson P, Davis CB. Zia-Amirhosseini P, et al. Among authors: davis cb. Pharm Res. 2000 Apr;17(4):385-90. doi: 10.1023/a:1007512617139. Pharm Res. 2000. PMID: 10870980

9

Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret.

Minthorn E, Mencken T, King AG, Shu A, Rominger D, Gontarek RR, Han C, Bambal R, Davis CB. Minthorn E, et al. Among authors: davis cb. Drug Metab Dispos. 2008 Sep;36(9):1846-52. doi: 10.1124/dmd.108.021758. Epub 2008 Jun 12. Drug Metab Dispos. 2008. PMID: 18556439

10

Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.

Davis CB, Garver EM, Kwok DC, Urbanski JJ. Davis CB, et al. Drug Metab Dispos. 1996 Sep;24(9):1032-7. Drug Metab Dispos. 1996. PMID: 8886616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters